Abon Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- Abon Pharmaceuticals's estimated annual revenue is currently $12.5M per year.
- Abon Pharmaceuticals's estimated revenue per employee is $201,000
Employee Data
- Abon Pharmaceuticals has 62 Employees.
- Abon Pharmaceuticals grew their employee count by -2% last year.
Abon Pharmaceuticals's People
Name | Title | Email/Phone |
---|---|---|
1 | EVP, Quality and Analytical Services | Reveal Email/Phone |
2 | Executive Director, Regulatory Affairs | Reveal Email/Phone |
3 | Executive Director | Reveal Email/Phone |
4 | Executive Director, Formulation R&D | Reveal Email/Phone |
5 | Executive Director | Reveal Email/Phone |
6 | Manager | Reveal Email/Phone |
7 | Principal Scientist | Reveal Email/Phone |
8 | Chemist | Reveal Email/Phone |
9 | president and CEO | Reveal Email/Phone |
10 | Validation Engineer | Reveal Email/Phone |
Abon Pharmaceuticals Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5M | 25 | -11% | N/A | N/A |
#2 | $35.8M | 178 | 8% | N/A | N/A |
#3 | $5.4M | 27 | -25% | N/A | N/A |
#4 | $4180M | 14516 | 1% | $550M | N/A |
#5 | $12.5M | 62 | 15% | N/A | N/A |
#6 | $6.7M | 119 | -37% | $199.6M | N/A |
#7 | $9.4M | 47 | 7% | N/A | N/A |
#8 | $10.3M | 51 | 6% | N/A | N/A |
#9 | $106.3M | 529 | 16% | N/A | N/A |
#10 | $15.5M | 77 | 20% | N/A | N/A |
What Is Abon Pharmaceuticals?
Abon Pharmaceuticals, LLC is a specialty pharma company and preferred partner in the development of difficult proprietary and generic products with high formulation barriers. Abon is capable of developing a broad range of dosage forms with the highest quality and speed.
keywords:N/AN/A
Total Funding
62
Number of Employees
$12.5M
Revenue (est)
-2%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $16.5M | 73 | 3% | N/A |
#2 | $21.6M | 88 | N/A | N/A |
#3 | $16.3M | 148 | 2% | N/A |
#4 | $47.2M | 188 | -1% | N/A |
#5 | $94.9M | 310 | 5% | N/A |